Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway-Reference-Cited by-同舟云学术

Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway

Published:2017-09-18 Issue:49 Volume:8 Page:86098-86116
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dai Guo¹,Zheng Di¹,Wang Qianliang²,Yang Jian¹,Liu Gaiwei¹,Song Qi¹,Sun Xiangran¹,Tao Chunjie¹,Hu Qingzhu¹,Gao Tian³,Yu Ling¹,Guo Weichun¹

Affiliation:

1. Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, P. R. China

2. Department of Urology Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, P. R. China

3. Department of Orthopedic Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital & Institute, Beijing 100000, P. R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The most recent progress of baicalein in its anti-neoplastic effects and mechanisms;Biomedicine & Pharmacotherapy;2024-07

2. Baicalein targets STMN1 to inhibit the progression of nasopharyngeal carcinoma via regulating the Wnt/β‐catenin pathway;Environmental Toxicology;2024-02-05

3. The Targeted Therapies for Osteosarcoma via Six Major Pathways;Current Molecular Pharmacology;2023-10-11

4. Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics;Nutrients;2023-04-26

5. Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives;Cancers;2023-04-03